Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I ROBERTSON

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
British Journal of Clinical Pharmacology|October 1, 1979
Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertensionA M Cummings, J J Brown, R Fraser, et al.
Circulation Research|June 1, 1975
Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in manW Oelkers, M Schöneshöfer, G Schultze, et al.
Clinical and Experimental Hypertension|January 1, 1980
Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibitionA B Atkinson, J J Brown, R Fraser, et al.
British Medical Journal|April 4, 1970
Falsely high plasma potassium values in patients with hyperaldosteronismJ J Brown, R H Chinn, D L Davies, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranololE A Rosei, P M Trust, J J Brown, et al.
British Journal of Clinical Pharmacology|August 1, 1976
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranololP M Trust, E A Rosei, J J Brown, et al.
Journal of Clinical Hypertension|September 1, 1986
Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal manL S Malatino, P Manhem, S G Ball, et al.
Journal of Hypertension|October 1, 1987
Dietary sodium deprivation raises blood pressure in the rat but does not produce irreversible hyperaldosteronismD J Webb, S A Clark, W B Brown, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronismC Beretta-Piccoli, P Weidmann, M G Bianchetti, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1978
Amiloride in the treatment of primary hyperaldosteronism and essential hypertensionD Kremer, K Boddy, J J Brown, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
British Journal of Clinical Pharmacology|October 1, 1979
Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertensionA M Cummings, J J Brown, R Fraser, et al.
Circulation Research|June 1, 1975
Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in manW Oelkers, M Schöneshöfer, G Schultze, et al.
Clinical and Experimental Hypertension|January 1, 1980
Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibitionA B Atkinson, J J Brown, R Fraser, et al.
British Medical Journal|April 4, 1970
Falsely high plasma potassium values in patients with hyperaldosteronismJ J Brown, R H Chinn, D L Davies, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranololE A Rosei, P M Trust, J J Brown, et al.
British Journal of Clinical Pharmacology|August 1, 1976
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranololP M Trust, E A Rosei, J J Brown, et al.
Journal of Clinical Hypertension|September 1, 1986
Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal manL S Malatino, P Manhem, S G Ball, et al.
Journal of Hypertension|October 1, 1987
Dietary sodium deprivation raises blood pressure in the rat but does not produce irreversible hyperaldosteronismD J Webb, S A Clark, W B Brown, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronismC Beretta-Piccoli, P Weidmann, M G Bianchetti, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1978
Amiloride in the treatment of primary hyperaldosteronism and essential hypertensionD Kremer, K Boddy, J J Brown, et al.
Pageof 18